Eureka Therapeutics
Cheng Liu began their career as a Graduate Student at UC Berkeley in 1990. In 1997, they joined Chiron/Novartis as a Principal Scientist. In 2006, they became the CEO of Eureka Therapeutics, Inc.
Cheng Liu attended Peking University from 1984 to 1990 and obtained a BS in Biology. Cheng then attended University of California, Berkeley from 1990 to 1996 and obtained a Doctor of Philosophy (Ph.D.).
This person is not in any offices
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.